Those samples with microscopically confirmed nasopharyngeal cancer were tested for EBNA1, LMP1, CD4, CD8, and FOXP3 concentration with ELISA, then verified with IHC. The gene discussed is FOXP3; the disease is nasopharyngeal carcinoma.